Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.
Melia BM, Abramson DH, Albert DM, Boldt HC, Earle JD, Hanson WF, Montague P, Moy CS, Schachat AP, Simpson ER, Straatsma BR, Vine AK, Weingeist TA; Collaborative Ocular Melanoma Study Group. Melia BM, et al. Among authors: earle jd. Ophthalmology. 2001 Feb;108(2):348-66. doi: 10.1016/s0161-6420(00)00526-1. Ophthalmology. 2001. PMID: 11158813 Clinical Trial.
Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.
Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, Hawkins BS, Hayman JA, Jaiyesimi I, Jampol LM, Kirkwood JM, Koh WJ, Robertson DM, Shaw JM, Straatsma BR, Thoma J; Collaborative Ocular Melanoma Study Group. Diener-West M, et al. Among authors: earle jd. Arch Ophthalmol. 2005 Dec;123(12):1639-43. doi: 10.1001/archopht.123.12.1639. Arch Ophthalmol. 2005. PMID: 16344433
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17.
Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM, Schachat AP, Straatsma BR; Collaborative Ocular Melanoma Study Group. Diener-West M, et al. Among authors: earle jd. Arch Ophthalmol. 2001 Jul;119(7):951-65. doi: 10.1001/archopht.119.7.951. Arch Ophthalmol. 2001. PMID: 11448318 Clinical Trial.
Enucleation versus plaque irradiation for choroidal melanoma.
Straatsma BR, Fine SL, Earle JD, Hawkins BS, Diener-West M, McLaughlin JA. Straatsma BR, et al. Among authors: earle jd. Ophthalmology. 1988 Jul;95(7):1000-4. doi: 10.1016/s0161-6420(88)33086-1. Ophthalmology. 1988. PMID: 3174030
Second primary cancers after enrollment in the COMS trials for treatment of choroidal melanoma: COMS Report No. 25.
Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, Hawkins BS, Hayman JA, Jaiyesimi I, Kirkwood JM, Koh WJ, Robertson DM, Shaw JM, Straatsma BR, Thoma J; Collaborative Ocular Melanoma Study Group. Diener-West M, et al. Among authors: earle jd. Arch Ophthalmol. 2005 May;123(5):601-4. doi: 10.1001/archopht.123.5.601. Arch Ophthalmol. 2005. PMID: 15883277 Clinical Trial.
Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
Melia M, Moy CS, Reynolds SM, Hayman JA, Murray TG, Hovland KR, Earle JD, Kurinij N, Dong LM, Miskala PH, Fountain C, Cella D, Mangione CM; Collaborative Ocular Melanoma Study-Quality of Life Study Group. Melia M, et al. Among authors: earle jd. Arch Ophthalmol. 2006 Feb;124(2):226-38. doi: 10.1001/archopht.124.2.226. Arch Ophthalmol. 2006. PMID: 16476893 Clinical Trial.
Choroidal melanoma treatment with iodine 125 brachytherapy.
Garretson BR, Robertson DM, Earle JD. Garretson BR, et al. Among authors: earle jd. Arch Ophthalmol. 1987 Oct;105(10):1394-7. doi: 10.1001/archopht.1987.01060100096035. Arch Ophthalmol. 1987. PMID: 3310986
118 results